Immutep Ltd ADR Earnings

The next earnings date for Immutep Ltd ADR is September 2, 2026.

They are scheduled to announce earnings after the market closes that day.

Analyst Estimates of Immutep Ltd ADR Earnings

No Results.

Report Date	Estimated Earnings Per Share
No Results.

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Immutep Ltd ADR Earnings: Historical

Report Date	Before/After Market	Earnings Per Share	Surprise %
02/26/2026	After Market	---	---
12/03/2025	---	$0	---
09/02/2025	Before Market	---	---
02/26/2025	Before Market	---	---
02/28/2024	Before Market	$0	100.00%
11/29/2023	---	$0	---
08/29/2023	---	$-0.15	3.26%
05/31/2023	---	$0	---
02/24/2023	Before Market	$-0.15	3.26%
11/30/2022	---	$0	---
07/27/2022	After Market	$0	100.00%
06/01/2022	---	$0	---
02/22/2022	After Market	$0	100.00%
12/01/2021	---	$0	---
08/30/2021	Before Market	$0	100.00%
06/02/2021	---	$-0.01	---
02/23/2021	---	$-0.38	-5.56%
12/02/2020	---	$-0.01	---
08/25/2020	Before Market	$-0.01	---
06/03/2020	---	$-0.01	---
02/20/2020	---	$-0.01	---
11/27/2019	---	$-0.01	---
08/20/2019	Before Market	$-0.01	---
05/29/2019	---	$-0.01	---
02/27/2019	---	$-0.01	---
11/28/2018	---	$-0.01	---
08/21/2018	Before Market	$-0.01	---
05/30/2018	---	$-0.01	---
02/22/2018	---	$-0.01	---
12/31/2017	---	$-0.01	---
08/28/2017	Before Market	$-0.01	---
06/29/2017	---	$-0.08	---
02/24/2017	Before Market	$-0.01	97.67%
12/31/2016	---	$-0.01	---
08/31/2016	Before Market	$-0.01	---
06/30/2016	---	$-0.01	---
02/29/2016	Before Market	$-0.01	---
12/31/2015	---	$-0.10	---
08/28/2015	Before Market	$-0.10	---
06/30/2015	---	$-0.05	---
03/31/2015	---	$-0.05	---
12/31/2014	---	$-0.02	---
09/30/2014	---	$-0.02	---
06/30/2014	---	$-0.02	---
03/31/2014	---	$-0.02	---
12/31/2013	---	$-0.02	---
09/30/2013	---	$-0.02	---
06/30/2013	---	$-0.03	---
03/31/2013	---	$-0.03	---
12/31/2012	---	$-0.04	---
09/30/2012	---	$-0.04	---
06/30/2012	---	$-0.05	---
03/31/2012	---	$-0.05	---
12/31/2011	---	$-0.05	---
09/30/2011	---	$-0.04	---
06/30/2011	---	$-0.11	---
03/31/2011	---	$-0.10	---
12/31/2010	---	$-0.09	---

More About Immutep Ltd ADR

Website

https://www.immutep.com

Country

USA

Full Time Employees

Immutep Limited, a biotechnology company, engages in developing novel Lymphocyte Activation Gene-3 related immunotherapies for cancer and autoimmune diseases in Australia. Its lead product candidate is the eftilagimod alfa (efti or IMP321), a soluble LAG-3lg fusion based on LAG-3 immune control mechanism for the treatment of different types of cancers. The company's product pipeline also includes TACTI-004, which is in phase III clinical trial for the treatment of first line non-small cell lung cancer (1L NSCLC); TACTI-003, which is in phase IIb clinical trial to treat first line head and neck squamous cell carcinoma (HNSCC); INSIGHT-005 which is in phase I for metastatic urothelial carcinoma; TACTI-002, which in phase II trial for the treatment NSCLC and HNSCC; AIPAC-003, which is in phase II/III clinical trial to treat metatastic breast cancer; and EFTISARC-NEO, which is in phase II clinical trial for the treatment of soft tissue sarcoma. It also develops INSIGHT-003, which is in phase I trial 1L non squamous NSCL; INSIGHT-005 that is in phase I to treat metastatic urothelial cancer; IMP761, which is in phase I Trial to treat autoimmune disease; IMP731 for oncology and autoimmune diseases; and LAG525. Immutep has collaboration with Merck & Co., Inc., EOC Pharma, Novartis, and Laboratory Corporation of America Holdings. The company was formerly known as Prima BioMed Ltd and changed its name to Immutep Limited in November 2017. The company was incorporated in 1987 and is based in Sydney, Australia.

“Immutep Ltd ADR Earnings” Can Refer to the Immutep Ltd ADR Earnings Date

Some people say “Immutep Ltd ADR earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Immutep Ltd ADR position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Immutep Ltd ADR Stock on the Earnings Date

If you own Immutep Ltd ADR stock (IMMP) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Immutep Ltd ADR might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Immutep Ltd ADR shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Immutep Ltd ADR Earnings

You can contact us any time if you would like to ask questions about Immutep Ltd ADR earnings or anything else related to the stock market.